Targeting oxidant-dependent mechanisms that drive COPD and its co-morbidities

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/1084627

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Chronic obstructive pulmonary disease (COPD) is a lung disease that is the 4th leading cause of death worldwide. There is currently no effective therapy to treat people with COPD, which costs the Australian community over $8.8 billion/year. Much of the disease burden and health care costs in COPD is associated with the management of its comorbidities (i.e other chronic medical conditions such as heart disease). This project will develop novel therapies to treat COPD and its comorbidities.

Funded Activity Details

Start Date: 01-01-2015

End Date: 01-01-2018

Funding Scheme: Project Grants

Funding Amount: $741,343.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Respiratory Diseases

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

chronic obstructive pulmonary disease (COPD) | comorbidity | emphysema | lung inflammation | oxidative stress

Related Links